Clinical Trial Update: Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the effectiveness of purified protein derivative therapy for treating anogenital warts in HIV-positive individuals; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anogenital Warts
• HIV Infection

Drugs mentioned

• Tuberculin Purified Protein Derivative (tuberculin purified protein derivative)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Anogenital Warts, HIV Infection | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING